Evidence map›Paper›PMID 39339758›Full record

ArticleNutrients2024

Hwan Hee Lee, Ji-Yeon Seong, Hyojeung Kang, Hyosun Cho

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hwan Hee LeeCollege of Pharmacy, Duksung Women's University, Seoul 01369, Republic of Korea.
Ji-Yeon SeongDuksung Innovative Drug Center, Duksung Women's University, Seoul 01369, Republic of Korea.
Hyojeung KangVessel-Organ Interaction Research Center, VOICE (MRC), Cancer Research Institute, College of Pharmacy, Kyungpook National University, Daegu 41566, Republic of Korea.ORCID 0000-0002-0622-5839
Hyosun ChoCollege of Pharmacy, Duksung Women's University, Seoul 01369, Republic of Korea.ORCID 0000-0001-9131-5742

Funding

JUYEONG NS Co., Ltd 202400020001National Research Foundation of Korea 2016R1A6A1A03007648National Research Foundation of Korea 2020R1A5A2017323
6 · The paper itself

Abstract

background

methodsIn vitro, the production of NO and cytokines and the mechanism of the signaling pathway of β-1,3-glucan were identified in RAW264.7 cells. In vivo, cyclophosphamide-induced (CP-induced) immunosuppressed C57BL/6 female mice were orally administered with three different concentrations (100, 300, and 600 mg/kg) of EP daily. After 14 days, the organs and whole blood were collected from each animal for further study.

resultsThe weight loss of CP-treated mice was reversed by treatment with EP to levels comparable to those of control mice. In addition, the frequencies of NK1.1

conclusions

Indexed as

Adaptive Immunitybeta-GlucansCyclophosphamideEuglena gracilisImmunity, InnateLectins, C-TypeMice, Inbred C57BLAnimalsCytokinesDectin-1FemaleGlucansImmunocompromised HostInterferon-gammaInterleukin-12Micebeta-1,3-glucanbeta-GlucansCyclophosphamideCytokinesDectin-1GlucansInterferon-gammaInterleukin-12Lectins, C-TypeparamylonTumor Necrosis Factor-alphacyclophosphamidedectin-1E. gracilisimmune-enhancing effectimmunosuppressed miceβ-1,3-glucan

Identifiers

PMID39339758
PMCPMC11434765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.